Skip to main content

Advertisement

SpringerLink
Log in

Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?

  • Original Article
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Secondary hyperparathyroidism (SHPTH) is present in many patients with end-stage renal disease (ESRD) and has been linked to uremic bone disease. Parathyroid hormone (PTH) levels are affected by calcium, vitamin D, and phosphorus. Recent data suggests that serum magnesium may also modulate PTH levels.

Objective

The aim of this retrospective study was to investigate the impact of different calcium (Ca) and magnesium (Mg) concentrations of dialysis solutions on serum Mg and serum PTH levels in peritoneal dialysis (PD) patients.

Patients and methods

Two groups of PD patients-group A (n = 17) on “standard” Ca and Mg dialysis solution (SCa–MgD) (Ca: 1.62 mmol/l, Mg: 0.75 mmol/l and Lactate 35 mmol/l), and group B (n = 29) on “low” Ca and Mg dialysis solution (LCa–MgD) (Ca: 1.25 mmol/l, Mg: 0.25 mmol/l and Lactate 40 mmol/l), on PD for more than 6 months, were studied. Calcium carbonate (CaCO3) was used as the phosphate (P) binder in 87% (40/46) of the patients. Biochemical parameters were evaluated every 1–2 months over 6 months and the mean values were computed.

Results

No significant differences were found between the two groups in all parameters except for serum Mg and PTH. Serum Mg was higher in SCa–MgD group compared to those in the LCa–MgD group (1.05 ± 0.19 vs 0.90 ± 0.23 mmol/l, respectively) and serum PTH was higher in LCa–MgD group compared to those in SCa–MgD group (72.3 ± 64.2 vs 31.1 ± 39.0 pmol/l, respectively) even though serum Ca was not different. There was a statistically significant inverse correlation between serum Mg and PTH levels (r =  −0.357, p < 0.05).

Conclusion

Serum Mg is lower and serum PTH higher in patients dialyzed with lower Mg concentration dialysis solution compared to those with higher Mg concentration dialysis solution. Our study confirms previous reports that serum Mg may have a suppressive role on PTH synthesis and/or secretion, and thus may play a role in pathogenesis of adynamic bone disease that often develops in patients on chronic PD with high calcium and high magnesium concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. MM Salem (1997) ArticleTitleHyperparathyroidism in the hemodialysis population: a survey of 612 patients Am J Kidney Dis 29 IssueID6 862–865 Occurrence Handle9186071 Occurrence Handle1:STN:280:DyaK2szivFGqtQ%3D%3D

    PubMed  CAS  Google Scholar 

  2. JF Navarro ML Macia E Gallego et al. (1997) ArticleTitleSerum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 31 IssueID3 275–280 Occurrence Handle9249893 Occurrence Handle1:STN:280:DyaK2szptlertQ%3D%3D

    PubMed  CAS  Google Scholar 

  3. MS Cho KS Lee YK Lee et al. (2002) ArticleTitleRelationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate Korean J Intern Med 17 IssueID2 114–121 Occurrence Handle12164088 Occurrence Handle1:CAS:528:DC%2BD38XmsVWltb8%3D

    PubMed  CAS  Google Scholar 

  4. JF C Navarro Mora M Macia et al. (1999) ArticleTitleSerum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients Perit Dial Int 19 IssueID5 455–461

    Google Scholar 

  5. JF Navarro C Mora A Jimenez et al. (1999) ArticleTitleRelationship between serum magnesium and parathyroid hormone levels in hemodialysis patients Am J Kidney Dis 34 IssueID1 43–48 Occurrence Handle10401014 Occurrence Handle1:STN:280:DyaK1MzjtV2jug%3D%3D

    PubMed  CAS  Google Scholar 

  6. EM Brown (1991) ArticleTitleExtracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers Physiol Rev 71 IssueID2 371–411 Occurrence Handle2006218 Occurrence Handle1:CAS:528:DyaK3MXisVSksrk%3D

    PubMed  CAS  Google Scholar 

  7. O Ferment PE Garnier Y Touitou (1987) ArticleTitleComparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man J Endocrinol 113 IssueID1 117–122 Occurrence Handle3585222 Occurrence Handle1:CAS:528:DyaL2sXhsFSjsrw%3D

    PubMed  CAS  Google Scholar 

  8. KP Katopodis EL Koliousi EK Andrikos et al. (2003) ArticleTitleMagnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration Artif Organs 27 IssueID9 853–857 Occurrence Handle12940910 Occurrence Handle10.1046/j.1525-1594.2003.07193.x

    Article  PubMed  Google Scholar 

  9. AA Ejaz AP McShane VC Gandhi et al. (1995) ArticleTitleHypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution Perit Dial Int 15 IssueID1 61–64 Occurrence Handle7734563 Occurrence Handle1:STN:280:DyaK2M3lt1ensw%3D%3D

    PubMed  CAS  Google Scholar 

  10. AJ Hutchison AJ Were HF Boulton et al. (1996) ArticleTitleHypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations Nephron 72 IssueID1 52–58 Occurrence Handle8903861 Occurrence Handle1:CAS:528:DyaK28XhtVWqsrc%3D

    PubMed  CAS  Google Scholar 

  11. H Malluche MC Faugere (1990) ArticleTitleRenal bone disease 1990: an unmet challenge for the nephrologist Kidney Int 38 IssueID2 193–211 Occurrence Handle2205749 Occurrence Handle1:STN:280:DyaK3czosVSrtw%3D%3D

    PubMed  CAS  Google Scholar 

  12. DJ Sherrard G Hercz Y Pei et al. (1993) ArticleTitleThe spectrum of bone disease in end-stage renal failure—an evolving disorder Kidney Int 43 IssueID2 436–442 Occurrence Handle8441240 Occurrence Handle1:STN:280:DyaK3s7otVersQ%3D%3D

    PubMed  CAS  Google Scholar 

  13. D Zayour M Daouk W Medawar et al. (2004) ArticleTitlePredictors of bone mineral density in patients on hemodialysis Transplant Proc 36 IssueID5 1297–1301 Occurrence Handle15251316 Occurrence Handle1:STN:280:DC%2BD2czkvFGisQ%3D%3D Occurrence Handle10.1016/j.transproceed.2004.05.069

    Article  PubMed  CAS  Google Scholar 

  14. GB Spasovski AR Bervoets GJ Behets et al. (2003) ArticleTitleSpectrum of renal bone disease in end-stage renal failure patients not yet on dialysis Nephrol Dial Transplant 18 IssueID6 1159–1166 Occurrence Handle12748350 Occurrence Handle1:CAS:528:DC%2BD3sXjvFCmtbg%3D Occurrence Handle10.1093/ndt/gfg116

    Article  PubMed  CAS  Google Scholar 

  15. A Gal-Moscovici MM Popovtzer (2002) ArticleTitleParathyroid hormone-independent osteoclastic resorptive bone disease: a new variant of adynamic bone disease in haemodialysis patients Nephrol Dial Transplant 17 IssueID4 620–624 Occurrence Handle11917055 Occurrence Handle1:CAS:528:DC%2BD38XjsFGjs7s%3D Occurrence Handle10.1093/ndt/17.4.620

    Article  PubMed  CAS  Google Scholar 

  16. MM Couttenye PC D’Haese WJ Verschoren et al. (1999) ArticleTitleLow bone turnover in patients with renal failure Kidney Int Suppl 73 S70–76 Occurrence Handle10633468 Occurrence Handle1:STN:280:DC%2BD3c%2FpvFartw%3D%3D Occurrence Handle10.1046/j.1523-1755.1999.07308.x

    Article  PubMed  CAS  Google Scholar 

  17. T Akizawa E Kinugasa T Akiba et al. (1997) ArticleTitleIncidence and clinical characteristics of hypoparathyroidism in dialysis patients Kidney Int Suppl 62 S72–74 Occurrence Handle9350686 Occurrence Handle1:STN:280:DyaK1c%2FhtFOrug%3D%3D

    PubMed  CAS  Google Scholar 

  18. A Torres V Lorenzo D Hernandez et al. (1995) ArticleTitleBone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH Kidney Int 47 IssueID5 1434–1442 Occurrence Handle7637272 Occurrence Handle1:STN:280:DyaK2MzmsVarsQ%3D%3D

    PubMed  CAS  Google Scholar 

  19. D Hernandez MT Concepcion V Lorenzo et al. (1994) ArticleTitleAdynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis Nephrol Dial Transplant 9 IssueID5 517–523 Occurrence Handle7522307 Occurrence Handle1:STN:280:DyaK2cznslSjuw%3D%3D

    PubMed  CAS  Google Scholar 

  20. G Hercz Y Pei C Greenwood et al. (1993) ArticleTitleAplastic osteodystrophy without aluminum: the role of “suppressed” parathyroid function Kidney Int 44 IssueID4 860–866 Occurrence Handle8258962 Occurrence Handle1:STN:280:DyaK2c%2FotFKnsg%3D%3D

    PubMed  CAS  Google Scholar 

  21. H Ito E Kinugasa (2004) ArticleTitlePathogenesis of secondary hyperparathyroidism and renal bone disease Clin Calcium 14 IssueID5 720–725 Occurrence Handle15577032

    PubMed  Google Scholar 

  22. K Shiizaki S Sumikado T Akizawa (2004) ArticleTitleLow PTH level and adynamic bone disease in dialysis patients Clin Calcium 14 IssueID1 16–20 Occurrence Handle15576948 Occurrence Handle1:CAS:528:DC%2BD2cXhvFGhuro%3D

    PubMed  CAS  Google Scholar 

  23. G Coen (2005) ArticleTitleAdynamic bone disease: an update and overview J Nephrol 18 IssueID2 117–122 Occurrence Handle15931639

    PubMed  Google Scholar 

  24. MM Couttenye PC D’Haese WJ Verschoren et al. (1999) ArticleTitleLow bone turnover in patients with renal failure Kidney Int Suppl 73 S70–76 Occurrence Handle10633468 Occurrence Handle1:STN:280:DC%2BD3c%2FpvFartw%3D%3D Occurrence Handle10.1046/j.1523-1755.1999.07308.x

    Article  PubMed  CAS  Google Scholar 

  25. S Ghitu R Oprisiu L Benamar et al. (2000) ArticleTitleRenal osteodystrophy (3); its treatment in dialysis patients Nephrologie 21 IssueID8 413–424 Occurrence Handle11213385 Occurrence Handle1:STN:280:DC%2BD3M7is12qtg%3D%3D

    PubMed  CAS  Google Scholar 

  26. E Slatopolsky A Brown A Dusso (2005) ArticleTitleCalcium, phosphorus and vitamin D disorders in uremia Contrib Nephrol 149 261–271 Occurrence Handle15876849 Occurrence Handle1:CAS:528:DC%2BD2MXhtVWrurvJ

    PubMed  CAS  Google Scholar 

  27. X Yu Y Sabbagh SI Davis et al. (2005) ArticleTitleGenetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations Bone 36 IssueID6 971–977 Occurrence Handle15869926 Occurrence Handle1:CAS:528:DC%2BD2MXltFSltL4%3D Occurrence Handle10.1016/j.bone.2005.03.002

    Article  PubMed  CAS  Google Scholar 

  28. E Slatopolsky J Finch M Denda et al. (1996) ArticleTitlePhosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro J Clin Invest 97 IssueID11 2534–2540 Occurrence Handle8647946 Occurrence Handle1:CAS:528:DyaK28XjsFKjsL4%3D

    PubMed  CAS  Google Scholar 

  29. J Silver C Yalcindag A Sela-Brown et al. (1999) ArticleTitleRegulation of the parathyroid hormone gene by vitamin D, calcium and phosphate Kidney Int Suppl 73 S2–7 Occurrence Handle10633456 Occurrence Handle1:CAS:528:DC%2BD3cXivFKisQ%3D%3D Occurrence Handle10.1046/j.1523-1755.1999.07310.x

    Article  PubMed  CAS  Google Scholar 

  30. T Naveh-Many J Silver (1990) ArticleTitleRegulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat J Clin Invest 86 IssueID4 1313–1319 Occurrence Handle2212016 Occurrence Handle1:CAS:528:DyaK3cXmt1Gisro%3D

    PubMed  CAS  Google Scholar 

  31. E Slatopolsky (1998) ArticleTitleThe role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism Nephrol Dial Transplant 13 IssueIDSuppl 3 3–8 Occurrence Handle9568812 Occurrence Handle10.1093/ndt/13.suppl_3.3

    Article  PubMed  Google Scholar 

  32. J Silver T Naveh-Many (1994) ArticleTitleRegulation of parathyroid hormone synthesis and secretion Semin Nephrol 14 IssueID2 175–194 Occurrence Handle8177983 Occurrence Handle1:CAS:528:DyaK2cXjtFGqs7g%3D

    PubMed  CAS  Google Scholar 

  33. P Pietschmann W Woloszczuk H Pietschmann (1990) ArticleTitleIncreased serum osteocalcin levels in elderly females with vitamin D deficiency Exp Clin Endocrinol 95 IssueID2 275–278 Occurrence Handle2365024 Occurrence Handle1:STN:280:DyaK3czgs1amsg%3D%3D

    PubMed  CAS  Google Scholar 

  34. MS Calvo R Kumar H Heath (1990) ArticleTitlePersistently elevated parathyroid hormone secretion and action in young women after 4 weeks of ingesting high phosphorus, low calcium diets J Clin Endocrinol Metab 70 IssueID5 1334–1340 Occurrence Handle2335575 Occurrence Handle1:CAS:528:DyaK3cXktVGjsbg%3D Occurrence Handle10.1210/jcem-70-5-1334

    Article  PubMed  CAS  Google Scholar 

  35. LY Sun M Wang L Yang (2005) ArticleTitleStudy of calcium–phosphorous metabolism and intact parathyroid hormone levels in end stage renal disease patients Beijing Da Xue Xue Bao 37 IssueID2 147–150 Occurrence Handle15841142 Occurrence Handle1:CAS:528:DC%2BD2MXhtFGksrzP

    PubMed  CAS  Google Scholar 

  36. IN Cholst SF Steinberg PJ Tropper et al. (1984) ArticleTitleThe influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects N Engl J Med 310 IssueID19 1221–1225 Occurrence Handle6709029 Occurrence Handle1:CAS:528:DyaL2cXktFOgsrs%3D Occurrence Handle10.1056/NEJM198405103101904

    Article  PubMed  CAS  Google Scholar 

  37. O Ferment PE Garnier Y Touitou (1987) ArticleTitleComparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man J Endocrinol 113 IssueID1 117–122 Occurrence Handle3585222 Occurrence Handle1:CAS:528:DyaL2sXhsFSjsrw%3D

    PubMed  CAS  Google Scholar 

  38. IR Gough GA Balderson HM Lloyd et al. (1988) ArticleTitleThe effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism World J Surg 12 IssueID4 463–469 Occurrence Handle3420930 Occurrence Handle1:STN:280:DyaL1czjslOqtA%3D%3D Occurrence Handle10.1007/BF01655421

    Article  PubMed  CAS  Google Scholar 

  39. JA Delmez J Kelber KY Norword et al. (1996) ArticleTitleMagnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study Kidney Int 49 IssueID1 163–167 Occurrence Handle8770963 Occurrence Handle1:STN:280:DyaK28zms1ynuw%3D%3D

    PubMed  CAS  Google Scholar 

  40. V Parsons D Baldwin C Moniz et al. (1993) ArticleTitleSuccessful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders Nephron 63 IssueID4 379–383 Occurrence Handle8459870 Occurrence Handle1:STN:280:DyaK3s3htFGjtQ%3D%3D

    PubMed  CAS  Google Scholar 

  41. P Nilsson SG Johansson BG Danielson (1984) ArticleTitleMagnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium Nephron 37 IssueID1 25–29 Occurrence Handle6717701 Occurrence Handle1:STN:280:DyaL2c7ptFOmug%3D%3D

    PubMed  CAS  Google Scholar 

  42. S Takahashi K Okada M Yanai (1994) ArticleTitleMagnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients Perit Dial Int 14 IssueID1 75–78 Occurrence Handle8312420 Occurrence Handle1:STN:280:DyaK2c7ks1Wkuw%3D%3D

    PubMed  CAS  Google Scholar 

  43. P Pletka DS Bernstein CL Hampers et al. (1974) ArticleTitleRelationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis Metabolism 23 IssueID7 619–630 Occurrence Handle4600477 Occurrence Handle1:STN:280:DyaE2c3mt1KlsQ%3D%3D

    PubMed  CAS  Google Scholar 

  44. RJ McGonigle MJ Weston J Keenan et al. (1984) ArticleTitleEffect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy Magnesium 3 IssueID1 1–7 Occurrence Handle6482508 Occurrence Handle1:STN:280:DyaL2M%2FhtFeltQ%3D%3D

    PubMed  CAS  Google Scholar 

  45. T Gohda I Shou M Fukui et al. (2002) ArticleTitleParathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients Am J Kidney Dis 39 IssueID6 1255–1260 Occurrence Handle12046039 Occurrence Handle1:CAS:528:DC%2BD38XkvFGgtrg%3D Occurrence Handle10.1053/ajkd.2002.33399

    Article  PubMed  CAS  Google Scholar 

  46. JY Guh HC Chen HY Chuang et al. (2002) ArticleTitleRisk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients Am J Kidney Dis 39 IssueID6 1245–1254 Occurrence Handle12046038 Occurrence Handle10.1053/ajkd.2002.33398

    Article  PubMed  Google Scholar 

  47. C Sanchez F Lopez-Barea J Sanchez-Cabezudo et al. (2004) ArticleTitleLow vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study Nephrol Dial Transplant 19 IssueID6 1587–1593 Occurrence Handle15069173 Occurrence Handle1:CAS:528:DC%2BD2cXkt1SqsrY%3D Occurrence Handle10.1093/ndt/gfh214

    Article  PubMed  CAS  Google Scholar 

  48. HH Saha AP Harmoinen AI Pasternack (1997) ArticleTitleMeasurement of serum ionized magnesium in CAPD patients Perit Dial Int 17 IssueID4 347–352 Occurrence Handle9284461 Occurrence Handle1:STN:280:DyaK2svjtVWlsg%3D%3D

    PubMed  CAS  Google Scholar 

  49. JF Navarro C Mora J Garcia et al. (1998) ArticleTitleHypermagnesemia in CAPD. Relationship with parathyroid hormone levels Perit Dial Int 18 IssueID1 77–80 Occurrence Handle9527035 Occurrence Handle1:STN:280:DyaK1c7os1agsw%3D%3D

    PubMed  CAS  Google Scholar 

  50. H Miki PB Maercklein LA Fitzpatrick (1997) ArticleTitleEffect of magnesium on parathyroid cells: evidence for two sensing receptors or two intracellular pathways? Am J Physiol 272 IssueID1 Pt 1 E1–6 Occurrence Handle9038844 Occurrence Handle1:CAS:528:DyaK2sXhtFKkt7g%3D

    PubMed  CAS  Google Scholar 

  51. SG Massry JW Coburn CR Kleeman (1970) ArticleTitleEvidence for suppression of parathyroid gland activity by hypermagnesemia J Clin Invest 49 IssueID9 1619–1629 Occurrence Handle5449702 Occurrence Handle1:CAS:528:DyaE3cXltFyitLs%3D Occurrence Handle10.1172/JCI106379

    Article  PubMed  CAS  Google Scholar 

  52. R O’Donovan D Baldwin M Hammer et al. (1986) ArticleTitleSubstitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia Lancet 1 IssueID8486 880–882 Occurrence Handle2870354 Occurrence Handle1:STN:280:BimC2szns1c%3D Occurrence Handle10.1016/S0140-6736(86)90987-6

    Article  PubMed  CAS  Google Scholar 

  53. GM Shah RL Winer RE Cutler et al. (1987) ArticleTitleEffects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis Am J Kidney Dis 10 IssueID4 268–275 Occurrence Handle3661548 Occurrence Handle1:STN:280:DyaL1c%2FitFSjug%3D%3D

    PubMed  CAS  Google Scholar 

  54. H Roujouleh S Lavaud O Toupance et al. (1987) ArticleTitleMagnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload Nephrol 8 IssueID2 45–50 Occurrence Handle1:STN:280:DyaL2s3oslGjsg%3D%3D

    CAS  Google Scholar 

  55. RD Lindeman (1986) ArticleTitleChronic renal failure and magnesium metabolism Magnesium 5 IssueID5–6 293–300 Occurrence Handle3807422 Occurrence Handle1:CAS:528:DyaL2sXkslyrsg%3D%3D

    PubMed  CAS  Google Scholar 

  56. AP Guillot VL Hood CF Runge et al. (1982) ArticleTitleThe use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis Nephron 30 IssueID2 114–117 Occurrence Handle7099318 Occurrence Handle1:STN:280:DyaL383ksFKrsg%3D%3D Occurrence Handle10.1159/000182446

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Home Peritoneal Dialysis Unit, University Health Network and University of Toronto, Toronto, Ontario, Canada

    Mingxin Wei, Khaled Esbaei, Joanne M. Bargman & Dimitrios G. Oreopoulos

  2. Department of Nephrology, Guangxi People’s Hospital, 6 Taoyuan Road, 530021, Nanning City, Guangxi, P.R. China

    Mingxin Wei

  3. Central Hospital, Al-Fatah University, Tripoli, Libya

    Khaled Esbaei

Authors
  1. Mingxin Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khaled Esbaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanne M. Bargman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dimitrios G. Oreopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mingxin Wei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wei, M., Esbaei, K., Bargman, J.M. et al. Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?. Int Urol Nephrol 38, 317–322 (2006). https://doi.org/10.1007/s11255-006-0082-6

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-0082-6

Keywords

Search

Navigation